NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistanceMaria Rita Emma, Melchiorre Cervello|Cell Death and Disease|2016Cited by 141
Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generationAntonella Cusimano, Melchiorre Cervello|International Journal of Oncology|2017Cited by 94
Nanostructured Lipid Carriers-Containing Anticancer Compounds: Preparation, Characterization, and Cytotoxicity StudiesMaria Luisa Bondı̀, Girolamo Cirrincione, Antonina Azzolina et al.|Drug Delivery|2007Cited by 72
Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer CellsMelchiorre Cervello, Giuseppe Montalto|PLoS ONE|2013Cited by 50
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cellsGiuseppa Augello, Melchiorre Cervello|Cell Death and Disease|2018Cited by 47